Interpharm Holdings, Inc.
IPAH
$0.00
$0.000.00%
OTC PK
| 12/31/2007 | 09/30/2007 | 06/30/2007 | 03/31/2007 | 12/31/2006 | |
|---|---|---|---|---|---|
| Revenue | 69.21M | 70.48M | 75.59M | 76.70M | 72.90M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 69.21M | 70.48M | 75.59M | 76.70M | 72.90M |
| Cost of Revenue | 57.21M | 56.71M | 53.92M | 53.05M | 51.62M |
| Gross Profit | 12.00M | 13.77M | 21.67M | 23.66M | 21.28M |
| SG&A Expenses | 14.68M | 14.49M | 13.38M | 13.25M | 12.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 88.93M | 90.20M | 86.26M | 82.97M | 79.17M |
| Operating Income | -19.72M | -19.73M | -10.67M | -6.27M | -6.27M |
| Income Before Tax | -22.27M | -23.38M | -13.87M | -9.34M | -9.17M |
| Income Tax Expenses | 7.09M | -796.00K | 190.00K | -2.54M | -2.72M |
| Earnings from Continuing Operations | -29.36 | -22.58 | -14.06 | -6.80 | -6.45 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -29.36M | -22.58M | -14.06M | -6.80M | -6.45M |
| EBIT | -19.72M | -19.73M | -10.67M | -6.27M | -6.27M |
| EBITDA | -16.57M | -16.97M | -8.32M | -4.19M | -4.39M |
| EPS Basic | -0.51 | -0.36 | -0.26 | -0.18 | -0.20 |
| Normalized Basic EPS | -0.21 | -0.20 | -0.11 | -0.08 | -0.11 |
| EPS Diluted | -0.51 | -0.37 | -0.26 | -0.18 | -0.20 |
| Normalized Diluted EPS | -0.21 | -0.20 | -0.11 | -0.08 | -0.11 |
| Average Basic Shares Outstanding | 264.13M | 262.45M | 260.98M | 243.98M | 211.06M |
| Average Diluted Shares Outstanding | 264.13M | 262.45M | 264.11M | 247.12M | 214.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.00% | -0.55% | -0.88% | -3.04% | -3.21% |